Posttranslational Modification of Deubiquitinating Enzymes in Neurodegeneration
Posttranslational Modification of Deubiquitinating Enzymes in Neurodegeneration
批准号:
8206841
负责人:
Sokol Todi
金额:
$24.52万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2013-11-30
关键词:
AddressAffectAlzheimer&aposs DiseaseAmericanAmyloid beta-Protein PrecursorAnimal ModelAnimalsAutophagocytosisAwardBehavioralBindingBinding SitesBiological AssayBrainCatalogingCatalogsCatalytic DomainCell Culture TechniquesCell LineCell NucleusCell modelCell physiologyCellsCleaved cellComputer SimulationDataDatabasesDeubiquitinating EnzymeDeubiquitinationDiseaseDisease modelDrosophila genusDrosophila melanogasterEyeFutureGeneticGoalsHeat Stress DisordersHomeostasisHumanIn VitroInstructionLigaseLinkLysineMJD1 proteinMachado-Joseph DiseaseMaintenanceMammalian CellManuscriptsModelingMolecularMolecular WeightMusNerve DegenerationNervous system structureNeurodegenerative DisordersNeurogliaNeuronsParkinson DiseasePathogenesisPathway interactionsPhasePhysiologicalPlayPositioning AttributePost-Translational Protein ProcessingProcessProteasome InhibitionProteinsPublicationsPublishingQuality ControlRNA InterferenceRecombinant ProteinsRegulationReportingResearchResourcesRoleSiteStressTertiary Protein StructureTestingUbiquitinUbiquitinationUp-RegulationUpdateWorkage relatedaging brainalpha synucleinataxin-1basecell typeflyfollow-upin vitro Assayinsightinterestlactacystinmembermouse modelmulticatalytic endopeptidase complexmutantneurotoxicpolyglutamineprotein degradationprotein functionprotein misfoldingresponsestressorsynucleintau Proteinstau mutationubiquitin-protein ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Neurodegeneration is closely linked to perturbations in protein quality control. Ubiquitin pathways are central
to protein quality control through their role in protein degradation. Here, I will investigate how deubiquitinating
enzymes (DUBs), integral components of ubiquitin-dependent pathways, are involved in neurodegenerative
processes and how DUBs themselves are regulated in turn. These studies focus on a unique DUB and the
polyglutamine disease protein in Spinocerebellar Ataxia Type 3, ataxin-3 (ATS), and USP25 and USP28, two
other brain-expressed DUBs that share domains with ATS.
ATS is a DUB that functions in protein quality control. I previously established that endogenous ATS is
ubiquitinated and its ubiquitination increases in proteotoxic stress. Importantly, ubiquitination directly
enhances ATS's catalytic activity. During the K99 phase I determined where ATS is ubiquitinated, gathered
nsight into the mechanism behind its ubiquitination-dependent activation, and collected evidence that ATS
ubiquitination is important for some of its cellular functions. Since ATS is neuroprotective in fly models of
neurodegeneration, during the ROO phase I will use Drosophila melanogaster models of neurodegeneration
to explore the role of ATS ubiquitination in its cytoprotective functions. I will generate fly lines expressing wild
type or non-ubiquitinatable ATS throughout the nervous system or in the eye. Through structural, behavioral
and electrophysiological studies I will examine whether ATS ubiquitination is important for its neuroprotective
role in intact animals. Complementary studies in mammalian cell culture will investigate the importance of
ATS ubiquitination in its ability to protect cells during proteotoxic stress.
USP25 and USP28 are two DUBs that, like ATS, have ubiquitin-interacting motifs (UIMs). UIMs facilitate host
protein ubiquitination; in fact, USP25 is ubiquitinated in cells. My preliminary data indicate that USP25 and
USP28 regulate cellular levels of Alzheimer's Disease-causing, mutant Amyloid Precursor Protein (APP).
Here, I will investigate the mechanisms by which USP25 and USP28 regulate APP by using cell-based and in
vitro assays. I will also examine how USP25 ubiquitination is involved in this cellular function. Finally, I will
begin to establish Drosophila assays to examine the role of other DUBs in neurodegeneration in the future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exercise-dependent mechanisms of protection in polyglutamine degeneration
-
批准号:10188094
-
项目类别:
-
资助金额:$42.35万
-
财政年份:2021
-
负责人:Sokol Todi
-
依托单位:
Unique ubiquitin processes in misfolded protein diseases of the nervous system
-
批准号:10284055
-
项目类别:
-
资助金额:$34.65万
-
财政年份:2021
-
负责人:Sokol Todi
-
依托单位:
Protection against Alzheimer's Disease proteins by novel ubiquitin processes
-
批准号:10283294
-
项目类别:
-
资助金额:$23.65万
-
财政年份:2014
-
负责人:Sokol Todi
-
依托单位:
Molecular Mechanisms of Neuroprotection in Polyglutamine-Dependent Degeneration
-
批准号:10115135
-
项目类别:
-
资助金额:$38.59万
-
财政年份:2014
-
负责人:Sokol Todi
-
依托单位:
Molecular Mechanisms of Neuroprotection in Polyglutamine-Dependent Degeneration
-
批准号:10369021
-
项目类别:
-
资助金额:$37.95万
-
财政年份:2014
-
负责人:Sokol Todi
-
依托单位:
Molecular Mechanisms of Neuroprotection in Polyglutamine-Dependent Degeneration
-
批准号:9811467
-
项目类别:
-
资助金额:$31.55万
-
财政年份:2014
-
负责人:Sokol Todi
-
依托单位:
Molecular Mechanisms of Neuroprotection in Polyglutamine-Dependent Degeneration
-
批准号:9018062
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2014
-
负责人:Sokol Todi
-
依托单位:
Molecular Mechanisms of Neuroprotection in Polyglutamine-Dependent Degeneration
-
批准号:8667610
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2014
-
负责人:Sokol Todi
-
依托单位:
Molecular Mechanisms of Neuroprotection in Polyglutamine-Dependent Degeneration
-
批准号:9234079
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2014
-
负责人:Sokol Todi
-
依托单位:
Posttranslational Modification of Deubiquitinating Enzymes in Neurodegeneration
-
批准号:8394928
-
项目类别:
-
资助金额:$23.0万
-
财政年份:2009
-
负责人:Sokol Todi
-
依托单位:
Posttranslational Modification of Deubiquitinating Enzymes in Neurodegeneration
-
批准号:7738174
-
项目类别:
-
资助金额:$8.56万
-
财政年份:2009
-
负责人:Sokol Todi
-
依托单位:
Posttranslational Modification of Deubiquitinating Enzymes in Neurodegeneration
-
批准号:8203082
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2009
-
负责人:Sokol Todi
-
依托单位:
海外基金